Spe­cial­ty drug mar­ket jumps, dri­ven by new users — not high­er price tags — and more biosim­i­lar up­take

The pre­scrip­tion spe­cial­ty drug mar­ket is re­bound­ing from a pan­dem­ic dip which isn’t sur­pris­ing, but what’s dri­ving it may be. A re­cent an­nu­al spend­ing and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER